112 related articles for article (PubMed ID: 19949849)
21. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
[TBL] [Abstract][Full Text] [Related]
23. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
[TBL] [Abstract][Full Text] [Related]
24. Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study.
Douros A; Tölle M; Ebert N; Gaedeke J; Huscher D; Kreutz R; Kuhlmann MK; Martus P; Mielke N; Schneider A; Schuchardt M; van der Giet M; Schaeffner E
Eur Heart J; 2019 Jul; 40(25):2021-2028. PubMed ID: 30805599
[TBL] [Abstract][Full Text] [Related]
25. Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men.
Thune I; Lund E
Cancer Causes Control; 1994 Nov; 5(6):549-56. PubMed ID: 7827242
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
Mehlum MH; Liestøl K; Kjeldsen SE; Julius S; Hua TA; Rothwell PM; Mancia G; Parati G; Weber MA; Berge E
Eur Heart J; 2018 Jun; 39(24):2243-2251. PubMed ID: 29365085
[TBL] [Abstract][Full Text] [Related]
27. Hypertension, antihypertensive drugs, and mortality from cancer among women.
Peeters PH; van Noord PA; Hoes AW; Grobbee DE
J Hypertens; 1998 Jul; 16(7):941-7. PubMed ID: 9794734
[TBL] [Abstract][Full Text] [Related]
28. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Jacobs EJ; Deka A; Patel AV; Bain EB; Thun MJ; Calle EE
Cancer Causes Control; 2009 Jul; 20(5):671-9. PubMed ID: 19067188
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure, smoking and body mass in relation to mortality from stroke and coronary heart disease in the elderly. A 10-year follow-up in Norway.
Ellekjaer H; Holmen J; Vatten L
Blood Press; 2001; 10(3):156-63. PubMed ID: 11688763
[TBL] [Abstract][Full Text] [Related]
30. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.
Engeland A; Tretli S; Bjørge T
Br J Cancer; 2003 Oct; 89(7):1237-42. PubMed ID: 14520453
[TBL] [Abstract][Full Text] [Related]
31. Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study.
Jochems SHJ; Häggström C; Stattin P; Järvholm B; Stocks T
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1483-1491. PubMed ID: 35511742
[TBL] [Abstract][Full Text] [Related]
32. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
[TBL] [Abstract][Full Text] [Related]
33. Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality.
Bassett JK; Severi G; Hodge AM; Baglietto L; Hopper JL; English DR; Giles GG
Cancer Causes Control; 2012 Jun; 23(6):855-63. PubMed ID: 22527163
[TBL] [Abstract][Full Text] [Related]
34. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
35. Low heart rates predict incident atrial fibrillation in healthy middle-aged men.
Grundvold I; Skretteberg PT; Liestøl K; Erikssen G; Engeseth K; Gjesdal K; Kjeldsen SE; Arnesen H; Erikssen J; Bodegard J
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):726-31. PubMed ID: 23873309
[TBL] [Abstract][Full Text] [Related]
36. Relationship of the Blood Pressure Categories, as Defined by the ACC/AHA 2017 Blood Pressure Guidelines, and the Risk of Development of Cardiovascular Disease in Low-Risk Young Adults: Insights From a Retrospective Cohort of Young Adults.
Kim S; Chang Y; Kang J; Cho A; Cho J; Hong YS; Zhao D; Ahn J; Shin H; Guallar E; Ryu S; Sung KC
J Am Heart Assoc; 2019 Jun; 8(11):e011946. PubMed ID: 31140347
[TBL] [Abstract][Full Text] [Related]
37. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
[TBL] [Abstract][Full Text] [Related]
38. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.
Pettersson A; Robinson D; Garmo H; Holmberg L; Stattin P
Ann Oncol; 2018 Feb; 29(2):377-385. PubMed ID: 29161337
[TBL] [Abstract][Full Text] [Related]
39. Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women.
Selmer R; Tverdal A
J Epidemiol Community Health; 1995 Jun; 49(3):265-70. PubMed ID: 7629461
[TBL] [Abstract][Full Text] [Related]
40. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men.
Veierød MB; Laake P; Thelle DS
Int J Cancer; 1997 Nov; 73(5):634-8. PubMed ID: 9398038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
